2025-08-28 21:03:18
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Metropolis Healthcare Ltd consolidated Q2 FY2022-23 net profit up QoQ at Rs. 40.33 crores
Posted On : 2022-11-08 22:10:39( TIMEZONE : IST )
Metropolis Healthcare Limited has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 304.6844 crores during the period ended September 30, 2022 as compared to Rs. 282.8975 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 40.3313 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 33.3974 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 7.85 for the period ended September 30, 2022 as compared to Rs. 6.49 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 304.6844 crs | ₹282.8975 crs |  7.70% |
| Net Profit | ₹40.3313 crs | ₹33.3974 crs | 20.76% |
| EPS | ₹7.85 | ₹6.49 | 20.96% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 304.6844 crores during the period ended September 30, 2022 as compared to Rs.308.1924 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.40.3313 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.58.2665 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.7.85 for the period ended September 30, 2022 as compared to Rs.11.34 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 304.6844 crs | ₹308.1924 crs |  -1.14% |
| Net Profit | ₹40.3313 crs | ₹58.2665 crs | -30.78% |
| EPS | ₹7.85 | ₹11.34 | -30.78% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.587.5819 crores during the 6 Months period ended September 30, 2022 as compared to Rs.638.72 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.73.7287 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.133.1565 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.14.35 for the 6 Months period ended September 30, 2022 as compared to Rs.25.92 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹587.5819 crs | ₹638.72 crs | -8.01% |
| Net Profit | ₹73.7287 crs | ₹133.1565 crs | -44.63% |
| EPS | ₹14.35 | ₹25.92 | -44.64% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 1727.50 as compared to the previous close of Rs. 1748.45. The total number of shares traded during the day was 7496 in over 766 trades.
The stock hit an intraday high of Rs. 1765.95 and intraday low of 1710.00. The net turnover during the day was Rs. 13000065.00.
